Missiroli, S.; Perrone, M.; Boncompagni, C.; Borghi, C.; Campagnaro, A.; Marchetti, F.; Anania, G.; Greco, P.; Fiorica, F.; Pinton, P.;
et al. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers 2021, 13, 2297.
https://doi.org/10.3390/cancers13102297
AMA Style
Missiroli S, Perrone M, Boncompagni C, Borghi C, Campagnaro A, Marchetti F, Anania G, Greco P, Fiorica F, Pinton P,
et al. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers. 2021; 13(10):2297.
https://doi.org/10.3390/cancers13102297
Chicago/Turabian Style
Missiroli, Sonia, Mariasole Perrone, Caterina Boncompagni, Chiara Borghi, Alberto Campagnaro, Francesco Marchetti, Gabriele Anania, Pantaleo Greco, Francesco Fiorica, Paolo Pinton,
and et al. 2021. "Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer" Cancers 13, no. 10: 2297.
https://doi.org/10.3390/cancers13102297
APA Style
Missiroli, S., Perrone, M., Boncompagni, C., Borghi, C., Campagnaro, A., Marchetti, F., Anania, G., Greco, P., Fiorica, F., Pinton, P., & Giorgi, C.
(2021). Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers, 13(10), 2297.
https://doi.org/10.3390/cancers13102297